Vietnam Medical and Pharmaceutical Investment JSC (HOSE:JVC)
Vietnam · Delayed Price · Currency is VND 3,050.00
0.00 (0.00%)
At close: Aug 13, 2026
HOSE:JVC Revenue
Vietnam Medical and Pharmaceutical Investment JSC had revenue of 142.37B VND in the quarter ending June 30, 2026, with 4.47% growth. This brings the company's revenue in the last twelve months to 747.22B, up 14.41% year-over-year. In the year 2025, Vietnam Medical and Pharmaceutical Investment JSC had annual revenue of 763.15B with 24.79% growth.
Revenue (ttm)
747.22B
Revenue Growth
+14.41%
P/S Ratio
0.46
Revenue / Employee
4.47B
Employees
174
Market Cap
343.13B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 763.15B | 151.61B | 24.79% |
| Jan 1, 2025 | 611.54B | 35.25B | 6.12% |
| Jan 1, 2024 | 576.29B | 76.85B | 15.39% |
| Mar 31, 2017 | 499.43B | -7.91B | -1.56% |
| Mar 31, 2016 | 507.34B | -385.84B | -43.20% |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Construction Joint Stock Company 47 | 1.63T |
| Thanh Nam Group JSC | 1.23T |
| Savimex | 1.15T |
| JANUS Group JSC | 832.28B |
| Everpia JSC | 761.99B |
| Thua Thien Hue Construction Joint-Stock | 329.48B |
| Coma 18 Joint stock Company | 309.98B |
| Mien Dong JSC | 294.34B |